QureBio
ID: 17839505QureBio is a Shanghai-based biopharmaceutical company developing bispecific and multispecific antibody therapies targeting cancer, autoimmune, and inflammatory diseases. Founded by Dr. Xiangdong Qu, it partners with global biotech firms and has raised significant funding, including a ¥100M Series C1 round in 2025.
1
Funding Rounds
$14.0m
Money raised
Recent Funding Rounds
Overview
- Website:
- Business model: B2B
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Xi******* Qu | - | - | - |
Funding series
Funding Series Analysis
The company QureBio has raised a total of $14m in funding over 1 rounds.
Key Insights:
- QureBio June 2025 Series C Funding Round: $14m